Product Composition & Structure
Search a product, then expand its tree to see how it is built — components, single parts, materials and packaging, each with its share. You always see where you are inside the product, and a click takes you to the companies (actors) that make it.
Pharmaceutical Products incl. Contraceptives and Vaccines › Antineoplastic agents › Tyrosine kinase inhibitors › Acalabrutinib
Acalabrutinib
Product ID:
282158
1 materials 1 total parts
View companies that make this product
Filter:
-
Acalabrutinib active pharmaceutical ingredient 100% Sourceable products Acalabrutinib 93% Ibrutinib 72% Alectinib 64% Idelalisib 57% Venetoclax 56% Used In
Formulation
2 options — component shares are % of the finished formulation
Acalabrutinib Capsule Formulation
primary base: Acalabrutinib Pharmaceutical active ingredient
| Component | Role | Share | Sourceable matches |
|---|---|---|---|
| Microcrystalline Cellulose | Filler | ||
| Lactose Monohydrate | Filler | ||
| Acalabrutinib | Active pharmaceutical ingredient | ||
| Croscarmellose Sodium | Disintegrant | ||
| Magnesium Stearate | Lubricant | ||
| Colloidal Silicon Dioxide | Glidant |
Acalabrutinib Tablet Formulation
base: Acalabrutinib Pharmaceutical active ingredient
| Component | Role | Share | Sourceable matches |
|---|---|---|---|
| Microcrystalline Cellulose | Filler | ||
| Lactose Monohydrate | Filler | ||
| Acalabrutinib | Active pharmaceutical ingredient | ||
| Croscarmellose Sodium | Disintegrant | ||
| Magnesium Stearate | Lubricant | ||
| Colloidal Silicon Dioxide | Glidant |